TrialSignal transduction and targeted therapy2026

A randomized, double-blind, active-controlled phase 3 multicenter trial of rHSA for cirrhotic ascites.

Jidong Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.